ROSETTA GENOMICS LTD.

Insiders Rosetta Genomics Ltd.

Equities

ROSGQ

IL0011026494

Market Closed - OTC Markets Other stock markets 09:34:46 2024-02-12 am EST			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	-.--%

2018	Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd..	CI
2018	Rosetta Genomics Ltd.(NasdaqCM:ROSG) dropped from NASDAQ Composite Index	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rosetta Genomics Ltd. Announces Resignation of Ken Berlin as President and CEO, Effective April 18, 2018	18-04-10	CI
Rosetta Genomics Ltd. Announces Resignation of David Sidransky as Director	17-11-14	CI
Rosetta Genomics Ltd Announces Resignation of Yitzhak Peterburg as Director	17-02-14	CI
Rosetta Genomics Ltd. Appoints Mark R. Willig as Chief Commercial Officer	16-10-20	CI
Rosetta Genomics Ltd. Hires Ana C. Ward as Executive Vice President, Legal and Corporate Development	16-04-11	CI
Rosetta Genomics Ltd. Appoints Ana C. Ward as Executive Vice President, Legal and Corporate Development	16-02-29	CI
Rosetta Genomics Ltd. Appoints Maria Fe Paz as Interim Chief Medical Officer	15-11-04	CI
Rosetta Genomics, Ltd. Announces Resignation of E. Robert Wassman as Chief Medical Officer	15-09-21	CI
Rosetta Genomics Ltd. Appoints Douglas Sites as Executive Vice President of Sales and Marketing	14-08-18	CI
Rosetta Genomics Ltd. Appoints Kevin Watson as Director, Reimbursement-Managed Care	14-02-18	CI
Rosetta Genomics to Appoint Dr. Yitzhak Peterburg to its Board of Directors	12-11-08	CI
Rosetta Genomics, Ltd. Appoints E. Robert Wassman as Chief Medical Officer and Dganit Bar as Chief Scientific Officer, Effective October 22, 2012	12-10-11	CI
Rosetta Genomics, Ltd. Announces Executive Changes	12-08-20	CI
Rosetta Genomics, Ltd. Appoints Roy N. Davis to its Board of Directors	12-06-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW